secwatch.observer — SEC 8-K summary
======================================

Issuer:     Processa Pharmaceuticals, Inc. (PCSA)
CIK:        0001533743
Form:       8-K
Filed at:   2025-09-12T23:59:59+00:00
Accession:  0001493152-25-013108
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Processa shareholders approve 10x increase in authorized shares, reverse split up to 1:50
--------------------------------------------------------------------------------

- Approved increase of authorized common shares from 100M to 1B (13.7M for, 3.0M against).
- Approved reverse stock split at ratio 1:2 to 1:50, effective by Dec 31, 2026 (13.9M for).
- Approved amendment to 2019 Omnibus Incentive Plan to increase shares available (13.6M for).
- Adjournment proposal approved but not needed due to sufficient votes on substantive proposals.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1533743/000149315225013108/0001493152-25-013108-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1533743/000149315225013108/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-013108

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer